COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc. (TSX: CSCI) is trading at CA$9.35, about ₹633 at today's CAD/INR rate, as of 30 Sep 2026, 9:55 AM ET, up 1.08% today. Indian residents can buy COSCIENS Biopharma from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
CA$9.35
Today's high
CA$9.35
52 week low
CA$3.30
52 week high
CA$39.60
CSCI opened at CA$9.35, closed previously at CA$9.25, and has traded between CA$3.30 and CA$39.60 over the past 52 weeks.
About
COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.
Key statistics
Avg. volume
996.00
Market cap
CA$9.92M
P/E Ratio
-0.50
Price-to-sales ratio
0.85
Enterprise value
-$2.97M
Free cash flow yield
-428.03%
Debt-to-equity ratio
0.13
Return on equity
-274.82%
ROIC
-59.02%
Beta
1.90
Dividend yield
0.00%
Last dividend
CA$0.00
Financial overview
Revenue
$7.63M
Earnings per share
-$29.97
Free cash flow
-$9.34M
Net profit margin
-57.93%
Gross margin
45.30%
EBITDA
-$9.41M
Revenue growth
-20.42%
How to buy COSCIENS Biopharma from India
Indian residents can buy COSCIENS Biopharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to CAD.
Search for COSCIENS Biopharma and place an order
Find COSCIENS Biopharma by name or by its ticker, CSCI, and choose an order type. COSCIENS Biopharma trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your COSCIENS Biopharma position in CAD and INR. COSCIENS Biopharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in COSCIENS Biopharma from India
Trading and taxes when buying COSCIENS Biopharma from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCOSCIENS Biopharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy COSCIENS Biopharma stock?
Yes. COSCIENS Biopharma (CSCI) has been listed on the Toronto Stock Exchange since 1996, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to CAD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one COSCIENS Biopharma share cost in rupees?
One COSCIENS Biopharma share is CA$9.35 — about ₹633 at a CAD/INR rate of 67.65 on 29 Sep 2026. Both the COSCIENS Biopharma price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying COSCIENS Biopharma from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on COSCIENS Biopharma shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the CAD/INR rate on the purchase and the sale date, so the rupee move counts alongside the COSCIENS Biopharma price. Paasa issues a capital-gains statement for your return.
Does COSCIENS Biopharma pay a dividend?
No. COSCIENS Biopharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade COSCIENS Biopharma from India?
The Toronto Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when Canada is on standard time. Orders can only execute during that window.
Do I have to declare COSCIENS Biopharma shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your COSCIENS Biopharma holding, its cost and its closing value.
How do I sell COSCIENS Biopharma and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in CAD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on COSCIENS Biopharma?
Yes. COSCIENS Biopharma is priced in CAD, so your rupee outcome combines the CAD move with the CAD/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.